| dc.contributor.author | Orozco-Solano, Sofía | |
| dc.contributor.author | Silva-Castro, Martha Milena | |
| dc.contributor.author | Machuca González, Manuel | |
| dc.date.accessioned | 2024-01-18T09:43:56Z | |
| dc.date.available | 2024-01-18T09:43:56Z | |
| dc.date.issued | 2023-02-16 | |
| dc.identifier.citation | Orozco-Solano S, Silva-Castro MM, Machuca M. Case report: Serotoninergic and cholinergic syndromes induced by self-medication. Front Pharmacol. 2023 Feb 16;14:1080249. doi: 10.3389/fphar.2023.1080249. PMID: 36874029; PMCID: PMC9978782. | es |
| dc.identifier.issn | 1663-9812 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12412/4941 | |
| dc.description.abstract | Self-medication is a part of the self-care practices carried out by the elderly in their
environment. The aim of this case report is to show how the self-medication of
fluoxetine and dimenhydrinate in an older adult can induce serotoninergic and
cholinergic syndromes, showing symptoms such as nausea, tachycardia, tremor,
loss of appetite, memory loss, decreased vision, falls, and increased urination. An
older adult who has been diagnosed with arterial hypertension, dyslipidemia,
diabetes mellitus, and a recent diagnosis of essential thrombosis is the subject of
this case report. After the analysis of the case, cessation of fluoxetine was
recommended to avoid withdrawal symptoms, therefore decreasing the need
for dimenhydrinate and the medicines used for dyspepsia. After the
recommendation, the patient showed an improvement in the symptoms.
Finally, the comprehensive evaluation process of the medication in the
Medicines Optimization Unit achieved the detection of the problem and
improved the patient’s health condition. | es |
| dc.language.iso | eng | es |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.title | Case report: Serotoninergic and cholinergic syndromes induced by self-medication | es |
| dc.type | article | es |
| dc.identifier.doi | 10.3389/fphar.2023.1080249 | |
| dc.issue.number | 14 | es |
| dc.journal.title | Frontiers in Pharmacology | es |
| dc.page.initial | 1 | es |
| dc.page.final | 5 | es |
| dc.rights.accessRights | openAccess | es |
| dc.subject.keyword | Adverse drug reaction | es |
| dc.subject.keyword | Cholinergic Syndrome | es |
| dc.subject.keyword | Pharmaceutical Care | es |
| dc.subject.keyword | Comprehensive Medication Management | es |
| dc.subject.keyword | Case report | es |
| dc.subject.keyword | Serotonergic syndrome | es |
| dc.volume.number | Feb 16 | es |